I read the books that helped shape The Family, the cult founded by an Australian yoga teacher in the 1960s – when Western societies were newly fascinated by the East.
Articles on LSD
Displaying 1 - 20 of 37 articles
Psychedelic medicine is surging back into favour in 2025, but the very features that make these drugs promising may be the hardest to commercialise.
Magic mushrooms and LSD may do more than bend minds: they could fight inflammation linked to depression, arthritis and heart disease.
Several religious groups have historically used psychedelics for healing. Now, a growing number are pushing for their use as a way to mystical experiences.
There are fundamental flaws in psychedelics research. But I’m still intrigued by their potential.
Having long been considered to have ‘no accepted medical use’, psychedelics are finally being recognised as being beneficial for treating a range of mental health disorders.
We still don’t know a lot about how the networks of cells in the brain enable conscious experience.
The problem with prodrugs is we don’t know how big the problem is because they are so hard to identify.
The story of Anne Hamilton-Byrne’s cult The Family has been told in a non-fiction book and documentary, a novel, In the Clearing, and now a Disney+ series. What can stories like this teach us?
Receiving a cancer diagnosis and undergoing cancer treatment can be a traumatizing experience. Psychedelics like LSD, psilocybin and MDMA could help alleviate symptoms from cancer-related PTSD.
While ‘The Last of Us’ is a dramatic projection of a deadly fungal outbreak, it is based, if not in reality, in logic. And it’s a reminder that fungal infections are growing more resistant.
The early research suggests the drugs might be effective for some conditions. But scientists have safety concerns.
A 1971 law, and the parallel growth of an illegal economy, shaped South Africa’s unique cannabis landscape.
Alberta’s new policy on psychedelic-assisted therapy for mental illness may set a precedent that moves Canadians one step closer to accepting psychedelics as medicinal substances.
Society has very different attitudes to near-death experiences and psychedelics.
Growing interest in psychedelics has spurred new research decades after hallucinogenics were tested in Saskatchewan in the 1950s. And an unassuming common fish is proving a useful test subject.
Drugs like MDMA, ketamine, LSD and psylocibin may help heal the wounds of trauma - but more research is needed.
In a new research study, more than 900 people from around the world explain the challenges and benefits of microdosing LSD and psilocybin-containing mushrooms.
Popular accounts of the effects of microdosing don’t quite match the experience of long-term microdosers, according to this new research.
Most people assume drugs are illegal because they are dangerous, but the reasons aren’t related to their relative risk or harm.
Top contributors
-
PhD student in Clinical Psychology, York University, Canada
-
PhD Candidate, Congnitive Neuroscience, University of Toronto
-
Professor and Canada Research Chair in the History of Health & Social Justice, University of Saskatchewan
-
Senior Lecturer of Addiction, Edith Cowan University
-
Research fellow, Swinburne University of Technology
-
Associate Professor, Behavioural Pharmacology Research Unit, Johns Hopkins University
-
Research Assistant in Psychiatry, University of Cambridge
-
Honorary Academic and Research Fellow, University of Liverpool
-
Research Associate in Psychiatry, University of Cambridge
-
Wellcome Trust Fellow, Brunel University of London
-
Senior Research Fellow in Cognitive Science, Macquarie University
-
Lecturer, Psychology and Epidemiology, University of Liverpool
-
Professor, Psychiatry and Biobehavioral Sciences, University of California, Los Angeles
-
Senior Lecturer in International Political Economy, City St George's, University of London
-
Royal Literary Fellow, Lancaster University